The New York Times – Business:
“Returning more production to the United States will require a national approach and broad-based policy solutions,” the groups said in a letter to the White House.
The New York Times – Business:
“Returning more production to the United States will require a national approach and broad-based policy solutions,” the groups said in a letter to the White House.
The New York Times – Business:
The firm, which the U.S. government scrutinized for its ties to China, is angling for hundreds of thousands of advanced artificial intelligence chips in a deal that could be finalized this week.
The New York Times – Business:
The new service will combine the company’s TV shows, cable channels and broadcast network, including National Football League games.
The New York Times – Business:
The company, which serves airports in liberal cities on the coasts, has agreed to operate chartered flights for Immigration and Customs Enforcement.
The New York Times – Business:
The president has long complained that the United States pays more for medicines than other wealthy countries. But he offered no clear legal authority to mandate lower prices.
The New York Times – Business:
American Bitcoin, a cryptocurrency firm co-founded by Eric Trump, said it was merging with a company traded on the Nasdaq, the latest expansion of the family’s investments in crypto.
The New York Times – Business:
Austan D. Goolsbee, president of the Chicago Fed, said there was still a risk of higher consumer prices and slower growth amid elevated uncertainty about the White House’s trade policy.
The New York Times – Business:
The delays are the latest problem to plague the airport, where radar and radio communications have recently malfunctioned.
The New York Times – Business:
The president announced an executive order aimed at lowering U.S. drug costs, revisiting an idea that was blocked in court during his first term.
The New York Times – Business:
His promotion of the sugar substitute was a success. But later, as head of Monsanto, he faced blowback after the company rushed into genetically altered products.